Effectiveness of a third dose of BNT162b2 or mRNA-1273 vaccine for preventing post-vaccination COVID-19 infection: an observational study

Aditya Sharma, Gina Oda, Mark Holodniy
doi: https://doi.org/10.1101/2021.11.29.21266777

Article Information

doi 
https://doi.org/10.1101/2021.11.29.21266777
History 
  • November 30, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.

Author Information

  1. Aditya Sharma, MD1,*,
  2. Gina Oda, MS1 and
  3. Mark Holodniy, MD1,2
  1. 1US Department of Veterans Affairs, Public Health Program, Washington, DC and Palo Alto, CA
  2. 2Stanford University, Stanford, CA
  1. ↵*Correspondence
    Aditya Sharma MD, aditya.sharma{at}va.gov, US Department of Veterans Affairs, Public Health Program, Palo Alto, CA 94304
Back to top
Posted November 30, 2021.
Download PDF
Data/Code
Email
Effectiveness of a third dose of BNT162b2 or mRNA-1273 vaccine for preventing post-vaccination COVID-19 infection: an observational study
Aditya Sharma, Gina Oda, Mark Holodniy
medRxiv 2021.11.29.21266777; doi: https://doi.org/10.1101/2021.11.29.21266777
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area